Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
20.11
-0.52 (-2.52%)
At close: Mar 3, 2026, 4:00 PM EST
20.03
-0.08 (-0.40%)
After-hours: Mar 3, 2026, 7:00 PM EST
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $624.74 million as of March 3, 2026. Its market cap has increased by 610.56% in one year.
Market Cap
624.74M
Enterprise Value
512.33M
1-Year Change
610.56%
Ranking
Category
Stock Price
$20.11
Market Cap Chart
Since February 2, 2024, Alto Neuroscience's market cap has increased from $528.69M to $624.74M, an increase of 18.17%. That is a compound annual growth rate of 8.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 640.90M | 15.90% |
| Dec 31, 2025 | 552.98M | 384.71% |
| Dec 31, 2024 | 114.08M | -78.42% |
| Feb 2, 2024 | 528.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Replimune Group | 631.68M |
| Rigel Pharmaceuticals | 630.58M |
| Zura Bio | 628.08M |
| Lexicon Pharmaceuticals | 627.81M |
| Allogene Therapeutics | 624.75M |
| MeiraGTx Holdings | 608.51M |
| LB Pharmaceuticals | 607.43M |
| YD Bio | 603.34M |